Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Astrocytic network alterations have been reported in Alzheimer's disease (AD), but the underlying pathways have remained undefined. Here we measure astrocytic calcium, cerebral blood flow and amyloid-β plaques in vivo in a mouse model of AD using multiphoton microscopy. We find that astrocytic hyperactivity, consisting of single-cell transients and calcium waves, is most pronounced in reactive astrogliosis around plaques and is sometimes associated with local blood flow changes. We show that astroglial hyperactivity is reduced after P2 purinoreceptor blockade or nucleotide release through connexin hemichannels, but is augmented by increasing cortical ADP concentration. P2X receptor blockade has no effect, but inhibition of P2Y1 receptors, which are strongly expressed by reactive astrocytes surrounding plaques, completely normalizes astrocytic hyperactivity. Our data suggest that astroglial network dysfunction is mediated by purinergic signalling in reactive astrocytes, and that intervention aimed at P2Y1 receptors or hemichannel-mediated nucleotide release may help ameliorate network dysfunction in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, astrocytes in apposition to Aβ deposits are also 'hyperactive' and display higher resting Ca 2+ level, more frequent and larger Ca 2+ elevations, long-range coordinated Ca 2+ waves that are never seen in control mice 95, 98, 111 , as well as increased gliotranmission 112 .”
From Astrocyte function from information processing to cognition and cognitive impairment (2019) · cites this paper as [98]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“mGlu5 receptors 97 and P2Y1 receptors 98 , whose enhanced Gq-IP3-dependent Ca 2+ signaling can similarly contribute to astrocytic Ca 2+ alteration”
From Astrocyte function from information processing to cognition and cognitive impairment (2019) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · cited 1×
“In one astrocyte, spontaneous calcium activity occurs first in the soma (1) and subsequently propagates into an endfoot (2).”
BackgroundAstrocytes, from brain glue to communication elements: the revolution continues
Volterra, A., & Meldolesi, J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1722 · Cited by 1,770
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Astrocyte-mediated control of cerebral blood flow
Takano, T., Tian, G.-F., Peng, W., Lou, N., Libionka, W., Han, X., & Nedergaard, M. (2006) · Nature Neuroscience · doi:10.1038/nn1623 · Cited by 1,141
Cited by
Diversity of astrocyte functions and phenotypes in neural circuits
Khakh, B. S., & Sofroniew, M. V. (2015) · Nature Neuroscience · doi:10.1038/nn.4043 · Cited by 1,239
Astrocyte function from information processing to cognition and cognitive impairment
Santello, M., Toni, N., & Volterra, A. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0325-8 · Cited by 737
González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
“In addition, A β interacts with several types of surface receptors in astrocytes which leads to calcium entry, including purinergic receptor P2Y1 (Delekate et al., 2014), nicotinic receptors ( α 7-nAChRs) (Xiu et al., 2005; Lee et al., 2014), and glutamate metabotropic receptor mGluR5 (Grolla et al., 2013; Ronco et al…”
BackgroundElusive roles for reactive astrocytes in neurodegenerative diseases
Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453
Impairments of neural circuit function in Alzheimer's disease
Busche, M. A., & Konnerth, A. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0429 · Cited by 360
Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model
Reichenbach, N., Delekate, A., Plescher, M., Schmitt, F., Krauss, S., Blank, N., Halle, A., & Petzold, G. C. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809665 · Cited by 343
“…this mechanism remain to be elucidated, but may be related to the fact that P2Y1 receptors — which are important mediators of network imbalance in AD (Delekate et al , 2014; Reichen-bach et al , 2018) — as well as downstream astroglial calcium changes may activate astrogliosis and astrocytic Stat3…”
InfluentialSelf-citationGliotransmission: Beyond Black-and-White
Savtchouk, I., & Volterra, A. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0017-17.2017 · Cited by 325
“…circuital, and behavioral effects seen upon activation of multiple other astrocyte receptors, including purinergic P2Y1 (Santello et al., 2011; Delekate et al., 2014), endocannabinoid CB1 (Han et al., 2012; Martín et al., 2015), and cholinergic muscarinic (Takata et al., 2011; Navarrete et…”
BackgroundAstrogliosis: An integral player in the pathogenesis of Alzheimer's disease
Osborn, L. M., Kamphuis, W., Wadman, W. J., & Hol, E. M. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.001 · Cited by 312
“The frequency of cerebrovascular changes, namely vasodilation and vasoconstriction, in APPswePS1dE9 transgenic mice is higher with vasoconstriction dominating over dilation (Delekate et al., 2014).”
BackgroundInfluentialDeciphering the astrocyte reaction in Alzheimer's disease
Perez-Nievas, B. G., & Serrano-Pozo, A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00114 · Cited by 282
“Resting calcium level and frequency and synchrony of calcium transients are increased in reactive astrocytes from APP/PS1 mice (Kuchibhotla et al., 2009; Delekate et al., 2014).”
BackgroundLopez‐Rodriguez, A. B., Hennessy, E., Murray, C. L., Nazmi, A., Delaney, H. J., Healy, D., Fagan, S. G., Rooney, M., Stewart, E., Lewis, A., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12341 · Cited by 293
Probing the Complexities of Astrocyte Calcium Signaling
Shigetomi, E., Patel, S., & Khakh, B. S. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.003 · Cited by 268
“However, although it has been proposed that astrocyte Ca2+ signals can be triggered by action potential firing in some brain areas [5], within the cortex in vivo neither normal nor heightened Ca2+ signaling in AD model mice was the result of action potential firing in neurons [102].”
BackgroundInfluentialMedicinal chemistry of adenosine, P2Y and P2X receptors
Jacobson, K. A., & Müller, C. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.001 · Cited by 262
“An astrocytic P2Y1R was found to be hyperactivated in an Alzheimer’s disease model in the mouse (Delekate et al., 2014).”
BackgroundQuestions and (some) answers on reactive astrocytes
Escartin, C., Guillemaud, O., & Carrillo‐de Sauvage, M. (2019) · Glia · doi:10.1002/glia.23687 · Cited by 275
“…into the complexity of astrocyte functions in the normal brain (Bindocci et al., 2017; Chung et al., 2013; Martin, Bajo-Graneras, Moratalla, Perea, & Araque, 2015; Nimmerjahn & Bergles, 2015) and in disease (Bardehle et al., 2013; Delekate et al., 2014; John Lin et al., 2017; Yu et al., 2018).”
BackgroundATP as a multi-target danger signal in the brain
Rodrigues, R. J., Tomé, A. R., & Cunha, R. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00148 · Cited by 259
“…and Khakh, 2007) and promote astrocytic hyperactivity and astrogliosis upon mechanical injury (Franke et al., 2001), ischemic conditions (Sun et al., 2008) or AD (Delekate et al., 2014), which is known to interfere with neuronal repair and regeneration (McKeon et al., 1999; Tian et al., 2006).”
BackgroundCeyzériat, K., Ben Haim, L., Denizot, A., Pommier, D., Matos, M., Guillemaud, O., Palomares, M.-A., Abjean, L., Petit, F., Gipchtein, P., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0606-1 · Cited by 256
Mitochondria and Calcium in Alzheimer’s Disease: From Cell Signaling to Neuronal Cell Death
Calvo-Rodriguez, M., & Bacskai, B. J. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.004 · Cited by 254
Astrocyte dysfunction in Alzheimer disease
Acosta, C., Anderson, H. D., & Anderson, C. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24075 · Cited by 247
“This activity corresponds with increased frequency and amplitude of evoked intercellular astrocytic Ca21 waves (Kuchibhotla et al., 2009) and is prominent in the reactive astrocyte phenotype in close proximity to amyloid plaques (Delekate et al., 2014).”
BackgroundInfluentialHarada, K., Kamiya, T., & Tsuboi, T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00499 · Cited by 244
“However, whether ATP potentiates or inhibits synaptic transmission is still under debate because adenosine, a metabolite synthesized from ATP, usually inhibits synaptic activity via adenosine A1 receptors (Koizumi, 2010; Nam et al., 2012; Delekate et al., 2014).”
BackgroundUnravelling and Exploiting Astrocyte Dysfunction in Huntington’s Disease
Khakh, B. S., Beaumont, V., Cachope, R., Munoz-Sanjuan, I., Goldman, S. A., & Grantyn, R. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.05.002 · Cited by 235
Jiang, R., Diaz-Castro, B., Looger, L. L., & Khakh, B. S. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3693-15.2016 · Cited by 237
“…which are accompanied by elevated astrocyte Ca 2 signals (Ding et al., 2007; Takano et al., 2007; Ding et al., 2009; Kuchibhotla et al., 2009; Delekate et al., 2014), we found that astrocytes from R6/2 mice display significantly reduced spontaneous Ca 2 signals, which reflects the specific…”
BackgroundResultInfluentialReactive astrocytes in Alzheimer’s disease: A double-edged sword
Chun, H., & Lee, C. J. (2018) · Neuroscience Research · doi:10.1016/j.neures.2017.11.012 · Cited by 176
“The eleased ATP acts on astrocytic P2Y1 receptors and increases Ca2+ oncentrations in an autocrine manner (Delekate et al., 2014).”
BackgroundRossi, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.003 · Cited by 177
Aberrant Calcium Signals in Reactive Astrocytes: A Key Process in Neurological Disorders
Shigetomi, E., Saito, K., Sano, F., & Koizumi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040996 · Cited by 169
“ATP activates purinergic receptors in reactive astrocytes in an autocrine/paracrine fashion to contribute to Ca2+ waves [42,64].”
BackgroundResultInfluentialArbel-Ornath, M., Hudry, E., Boivin, J. R., Hashimoto, T., Takeda, S., Kuchibhotla, K. V., Hou, S., Lattarulo, C. R., Belcher, A. M., Shakerdge, N., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0169-9 · Cited by 166
“In vivo studies in AD mice have revealed that calcium transients in astrocytes were more frequent and synchronously coordinated in transgenic animals as compared with controls [63, 64], an effect potentially mediated by paracrine purinergic signaling that could be blocked by P2Y receptors inhibitors [65].”
Hefendehl, J. K., LeDue, J., Ko, R. W. Y., Mahler, J., Murphy, T. H., & MacVicar, B. A. (2016) · Nature Communications · doi:10.1038/ncomms13441 · Cited by 156
Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease
Shah, D., Gsell, W., Wahis, J., Luckett, E. S., Jamoulle, T., Vermaercke, B., Preman, P., Moechars, D., Hendrickx, V., Jaspers, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111280 · Cited by 164
Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications
Uddin, M. S., & Lim, L. W. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101622 · Cited by 145
Astrocyte regulation of neural circuit activity and network states
Oliveira, J. F., & Araque, A. (2022) · Glia · doi:10.1002/glia.24178 · Cited by 144
“…Oe et al., 2020; Paukert et al., 2014; Ye et al., 2020), GABA in the prefrontal cortex (Mederos et al., 2021), ATP in the cortex and hippocampus (Delekate et al., 2014; Reichenbach et al., 2018), serotonin in the nucleus of the solitary tract (Mastitskaya et al., 2020) and dopamine in the…”
BackgroundP2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer’s disease model
Reichenbach, N., Delekate, A., Breithausen, B., Keppler, K., Poll, S., Schulte, T., Peter, J., Plescher, M., Hansen, J. N., Blank, N., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171487 · Cited by 131
“Chronic P2Y1R inhibition reduces neuronal-astroglial network hyperactivity in APP PS1 mice We have previously shown that acute P2Y1R inhibition reduces astroglial network hyperactivity in APP PS1 mice (Delekate et al., 2014).”
BackgroundMethodResultInfluentialSelf-citationCa2+transients in astrocyte fine processes occur via Ca2+influx in the adult mouse hippocampus
Rungta, R. L., Bernier, L.-P., Dissing-Olesen, L., Groten, C. J., LeDue, J. M., Ko, R., Drissler, S., & MacVicar, B. A. (2016) · Glia · doi:10.1002/glia.23042 · Cited by 129
“, 2010), and astrocyte Ca(21) signaling has been shown to be altered surrounding amyloid-b plaques in a mouse models of Alzheimer’s disease (Delekate et al., 2014; Kuchibhotla et al., 2009).”
BackgroundTransgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R., Mejias-Ortega, M., Fernandez-Valenzuela, J. J., Nuñez-Diaz, C., Caceres-Palomo, L., Vegas-Gomez, L., Sanchez-Mejias, E., Trujillo-Estrada, L., Garcia-Leon, J. A., Moreno-Gonzalez, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 129
Novakovic, M. M., Korshunov, K. S., Grant, R. A., Martin, M. E., Abdala‐Valencia, H., Budinger, G. R. S., Radulović, J., & Prakriya, M. (2023) · Nature Communications · doi:10.1038/s41467-023-40968-6 · Cited by 144
“Elevated Ca 2+ signaling is tightly associated with reactive astrocytes and is observed in response to neuronal hyper-excitability, amyloid plaques, ischemia, and tissue damage 16,17 .”
Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer’s disease
Yi, C., Mei, X., Ezan, P., Mato, S., Matias, I., Giaume, C., & Koulakoff, A. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.63 · Cited by 139
“Cx43 HCswere proposed as a source of ATP release in a FAD model.(23) Therefore, we asked whether Cx channel functions,”
BackgroundNeurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy
Vasić, V., Barth, K., & Schmidt, M. H. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174272 · Cited by 142
“Aggregated Aβ induces an increased Ca2+ uptake in astrocytes by an enhanced activation of P2Y1 receptors [56], transient receptor potential channel 4 [57], nicotinic acid receptor [58,59] and the glutamate metabotropic receptor mGluR5 [60,61].”
BackgroundDiversity of astroglial responses across human neurodegenerative disorders and brain aging
Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 124
“Altered calcium signaling is found in models of AD (2, 3, 101, 153, 233, 358, 375, 432, 458), PD (48) and ALS (212, 281).”
Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective
Mulica, P., Grünewald, A., & Pereira, S. L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.668517 · Cited by 123
“In an AD mouse model, it was shown that astrocytes surrounding Ab plaques might generate aberrant Ca signals, which can be further propagated to other astrocytes (101, 102).”
BackgroundThe Many Faces of Astrocytes in Alzheimer's Disease
Monterey, M. D., Wei, H., Wu, X., & Wu, J. Q. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.619626 · Cited by 117
Neuron–astrocyte signaling is preserved in the aging brain
Gómez‐Gonzalo, M., Martin‐Fernandez, M., Martínez‐Murillo, R., Mederos, S., Hernández‐Vivanco, A., Jamison, S., Fernandez, A. P., Serrano, J., Calero, P., Futch, H. S., et al. (2017) · Glia · doi:10.1002/glia.23112 · Cited by 114
“On the other hand, astrocytic physiological dysfunctions, including alterations of the astrocyte calcium (Ca(21)) signal (Delekate et al., 2014; Kuchibhotla et al., 2009; Takano et al., 2007), have been related with the pathology of particular neurodegenerative diseases (Rudy et al.”
BackgroundRodríguez-Giraldo, M., González-Reyes, R. E., Ramírez-Guerrero, S., Bonilla-Trilleras, C. E., Guardo-Maya, S., & Nava-Mesa, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113630 · Cited by 111
Purinergic receptors as potential therapeutic targets in Alzheimer's disease
Woods, L. T., Ajit, D., Camden, J. M., Erb, L., & Weisman, G. A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.031 · Cited by 105
“…brain have significantly higher resting [Ca2þ]i levels than in wild type animals and exhibited increased propagation of intercellular calciumwaves near Ab plaques, which was suggested to contribute to Ab-induced neuronal damage and synapse loss (Kuchibhotla et al., 2009; Delekate et al., 2014).”
Yi, C., Ezan, P., Fernández, P., Schmitt, J., Sáez, J. C., Giaume, C., & Koulakoff, A. (2017) · Glia · doi:10.1002/glia.23182 · Cited by 105
“, 1997) and in FAD mice, ATP and glutamate release was higher than in WT mice (Delekate et al., 2014; Yi et al., 2016).”
BackgroundBosson, A., Paumier, A., Boisseau, S., Jacquier-Sarlin, M., Buisson, A., & Albrieux, M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0194-8 · Cited by 103
“Within somatosensory cortex, this astrocyte hyperactivity around plaques is mediated by purinergic signaling [13].”
BackgroundInfluentialAstroglia-Derived ATP Modulates CNS Neuronal Circuits
Illés, P., Burnstock, G., & Tang, Y. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.09.006 · Cited by 114
Specific and behaviorally consequential astrocyte Gq GPCR signaling attenuation in vivo with iβARK
Nagai, J., Bellafard, A., Qu, Z., Yu, X., Ollivier, M., Gangwani, M. R., Castro, B. D., Coppola, G., Schumacher, S. M., Golshani, P., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.023 · Cited by 112
“, 2020), is altered in disease (Alvarez-Ferradas et al., 2015; Delekate et al., 2014; Reichenbach et al., 2018), and mediates cell-cell communication in some settings in neural circuits of rodents (Adamsky et al.”
Paumier, A., Boisseau, S., Jacquier‐Sarlin, M. R., Pernet‐Gallay, K., Buisson, A., & Albrieux, M. (2021) · Brain · doi:10.1093/brain/awab281 · Cited by 118
Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease
Nanclares, C., Baraibar, A. M., Araque, A., & Kofuji, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157887 · Cited by 120
“Likewise, studies in vivo show that the enhanced calcium activity of astrocytes near Aβ plaques in APPPS1 mice is reduced after P2 purinoreceptor blockade [77].”
BackgroundAstroglial Calcium Signaling in Aging and Alzheimer's Disease
Verkhratsky, A. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035188 · Cited by 99
“This ATP, in turn, acts in an autocrine fashion on astroglial P2Y purinoceptors, which mediate abnormal [Ca]i dynamics (Delekate et al. 2014).”
BackgroundAstroglia in Alzheimer’s Disease
Verkhratsky, A., Parpura, V., Rodriguez, J. J., & Zorec, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_11 · Cited by 101
Purinergic signaling orchestrating neuron-glia communication
Agostinho, P. M., Madeira, D., Dias, L., Simões, A. P., Cunha, R. A., & Canas, P. M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105253 · Cited by 100
Toth, P., Tarantini, S., Davila, A., Valcarcel-Ares, M. N., Tucsek, Z., Varamini, B., Ballabh, P., Sonntag, W. E., Baur, J. A., Csiszar, A., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00463.2015 · Cited by 92
“The P2Y1 receptor is also involved in interastrocytic communication in both physiological (38) and pathological conditions (19).”
BackgroundGuzman, S. J., & Gerevich, Z. (2016) · Neural Plasticity · doi:10.1155/2016/1207393 · Cited by 108
“P2Y 1 receptor mediated Ca signaling [155].”
Presa, J., Saravia, F., Bagi, Z. A., & Filosa, J. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.584135 · Cited by 107
“Models of cerebrovascular pathology such as stroke (Morrison and Filosa, 2016; Morrison and Filosa, 2019) and AD, show increases in astrocyte Ca2+ events (Delekate et al., 2014).”
BackgroundCalcium signaling in neuroglia
(2021) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2021.01.003 · Cited by 85
Amyloid β‐induced astrogliosis is mediated by β1‐integrin via NADPH oxidase 2 in Alzheimer's disease
Wyssenbach, A., Quintela, T., Llavero, F., Zugaza, J. L., Matute, C., & Alberdi, E. (2016) · Aging Cell · doi:10.1111/acel.12521 · Cited by 82
“Indeed, reactive astrocytes near Ab plaques show impaired functions concerning Ca2+ network hyperactivity (Delekate et al., 2014) and an aberrant production of gliotransmitters (Jo et al., 2014) as well as disrupted astrocyte-toastrocyte topology (Galea et al., 2015).”
BackgroundCa2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases
Sompol, P., & Norris, C. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00199 · Cited by 82
“Similar functional indices of Ca2+ dysregulation have been noted in animal models of AD (Takano et al., 2007; Kuchibhotla et al., 2009; Delekate et al., 2014), brain edema (Thrane et al.”
BackgroundRole of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease
Baracaldo-Santamaría, D., Avendaño-Lopez, S. S., Ariza-Salamanca, D. F., Rodríguez-Giraldo, M., Calderón‐Ospina, C., González-Reyes, R. E., & Nava-Mesa, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109067 · Cited by 93
“2, the astrocytic hyperactivity seen around Aβ plaques has been attributed in part to the activation of P2Y1 receptors, which are metabotropic purinergic receptors on astrocytes that cause intracellular calcium elevation [189].”
BackgroundNikolic, L. M., Shen, W., Nobili, P., Virenque, A., Ulmann, L., & Audinat, É. (2018) · Glia · doi:10.1002/glia.23519 · Cited by 96
Zhang, M., Xu, L., & Yang, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071970 · Cited by 83
“The pathogenesis of NDs has been further elucidated in recent years, such as the mitochondrial mechanism of neuroglial crosstalk after stroke [128], phagocytosis of reactive astrocytes following brain ischemia [129], purinergic signaling in reactive astrocytes of AD [130], endothelial cytoskeletal reorganization in bl…”
BackgroundA stocked toolbox for understanding the role of astrocytes in disease
Almad, A., & Maragakis, N. J. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0010-2 · Cited by 85
Rakers, C., Schmid, M., & Petzold, G. C. (2017) · Glia · doi:10.1002/glia.23183 · Cited by 76
Self-citationRole of purinergic receptors in the Alzheimer’s disease
Cieślak, M., & Wojtczak, A. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9629-0 · Cited by 74
Functions of Astrocytes under Normal Conditions and after a Brain Disease
Vallés, S. L., Singh, S. K., Campos-Campos, J., Colmena, C., Campo-Palacio, I., Alvarez-Gamez, K., Caballero, Ó., & Jorda, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098434 · Cited by 86
“This happens because the Ca2+ concentration rises inside the cell [64].”
BackgroundSignaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease
Lian, H., & Zheng, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13424 · Cited by 77
“…astrocytes were shown to exhibit escalated basal calcium transients and intercellular calcium waves (Kuchibhotla et al. 2009; Riera et al. 2011; Delekate et al. 2014; Lim et al. 2014), which may trigger the release of toxic factors or dysregulation of neuronal calciumregulated receptors…”
BackgroundAn autocrine purinergic signaling controls astrocyte-induced neuronal excitation
Shen, W., Nikolic, L., Meunier, C., Pfrieger, F., & Audinat, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-11793-x · Cited by 75
Control of Macrophage Inflammation by P2Y Purinergic Receptors
Klaver, D., & Thurnher, M. (2021) · Cells · doi:10.3390/cells10051098 · Cited by 82
“In addition, macrophage-mediated inflammation may differentially affect P2Y1 function in other cell types [37,38].”
BackgroundA Central Role for ATP Signalling in Glial Interactions in the CNS
Rivera, A., Vanzulli, I., & Butt, A. (2016) · Current Drug Targets · doi:10.2174/1389450117666160711154529 · Cited by 74
“P2X1/5R-mediated calcium signalling in astrocytes was decreased in ageing (27, 70), and there is evidence in mouse models of AD of enhanced calcium signalling in astrocytes associated with P2Y1Rmediated release of ATP from reactive astrocytes (71).”
BackgroundMcConnell, H., Li, Z., Woltjer, R. L., & Mishra, A. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.005 · Cited by 83
“Reactive astrocytes surrounding Aβ plaques exhibit Ca2+ hyperactivity driven by metabotropic purinergic signaling (Delekate et al., 2014) and, in models of CAA, the vascular coverage by astrocyte endfeet is reduced with concurrent downregulation of K+ and AQP4 channels (Wilcock et al.”
BackgroundAstrocytic chloride is brain state dependent and modulates inhibitory neurotransmission in mice
Untiet, V., Beinlich, F. R. M., Kusk, P., Kang, N., Ladrón-de-Guevara, A., Song, W., Kjaerby, C., Andersen, M., Hauglund, N., Bojarowska, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37433-9 · Cited by 70
“…was next tested using an alternative approach: Astrocytes loaded with the Cl − dye MQAE were imaged while cell type identity was con fi rmed by co-labelling with astrocyte-speci fi c dye SR-101 45,46 which allowed to focus on astrocytes to exclude contamination from neuronal signalling (Fig.”
MethodDas, R., & Chinnathambi, S. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.09.024 · Cited by 70
Smit, T., Deshayes, N. A. C., Borchelt, D. R., Kamphuis, W., Middeldorp, J., & Hol, E. M. (2021) · Glia · doi:10.1002/glia.23981 · Cited by 71
Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications
Zarrinmayeh, H., & Territo, P. R. (2020) · Molecular Imaging · doi:10.1177/1536012120927609 · Cited by 77
Astroglial Scarring and Seizures: A Cell Biological Perspective on Epilepsy
Robel, S. (2016) · The Neuroscientist · doi:10.1177/1073858416645498 · Cited by 71
Yao, J., Sun, B., Institoris, A., Zhan, X., Guo, W., Song, Z., Liu, Y., Hiess, F., Boyce, A. K. J., Ni, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108169 · Cited by 65
“…our data to this considerable body of existing literature, we employed the same approach described originally by Busche et al. and used by others in the field (Busche et al., 2008, 2012; Delekate et al., 2014; Eichhoff and Garaschuk, 2011; Kim et al., 2016; Takano et al., 2007; Zott et al., 2019).”
BackgroundMethodMetabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease
Kumari, P., Sood, A., & Fernandes, V. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01147-7 · Cited by 70
Reverse NCX Attenuates Cellular Sodium Loading in Metabolically Compromised Cortex
Gerkau, N. J., Rakers, C., Durry, S., Petzold, G. C., & Rose, C. R. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx280 · Cited by 69
Self-citationThe Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
Hulshof, L. A., van Nuijs, D., Hol, E. M., & Middeldorp, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.899251 · Cited by 64
Astrocyte‐neuronal network interplay is disrupted in Alzheimer's disease mice
Lines, J., Baraibar, A. M., Fang, C. C., Martín, E. D., Aguilar, J., Lee, M. K., Araque, A., & Kofuji, P. (2021) · Glia · doi:10.1002/glia.24112 · Cited by 70
“From this, our results suggest that increased spontaneous activity, in agreement with others (Delekate et al., 2014; Kuchibhotla et al., 2009), lead to diminished sensory-evoked responses.”
ResultAstroglial activation: Current concepts and future directions
Edison, P. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13678 · Cited by 61
Identification of functional tRNA-derived fragments in senescence-accelerated mouse prone 8 brain
Zhang, S., Li, H., Zheng, L., Li, H., Feng, C., & Zhang, W. (2019) · Aging · doi:10.18632/aging.102471 · Cited by 69
“A study confirmed that the P2Y1 receptor contributed to astroglial network dysfunction by purinergic signaling in AD [31].”
BackgroundLocal Resting Ca2+ Controls the Scale of Astroglial Ca2+ Signals
King, C., Bohmbach, K., Minge, D., Delekate, A., Zheng, K., Reynolds, J. R., Rakers, C., Zeug, A., Petzold, G. C., Rusakov, D. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.043 · Cited by 61
Self-citationNeuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Rao, K. V. R., & Kielian, T. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12237 · Cited by 73
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Calvo-Rodríguez, M., Kharitonova, E. K., & Bacskai, B. J. (2020) · Cells · doi:10.3390/cells9112513 · Cited by 67
“This in turn activates P2Y purinoceptors mediating abnormal cytosolic Ca2+ signaling [17].”
BackgroundLia, A., Sansevero, G., Chiavegato, A., Sbrissa, M., Pendin, D., Mariotti, L., Pozzan, T., Berardi, N., Carmignoto, G., Fasolato, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37240-2 · Cited by 69
Mizuno, G. O., Wang, Y., Shi, G., Wang, Y., Sun, J., Papadopoulos, S., Broussard, G. J., Unger, E. K., Deng, W., Weick, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.033 · Cited by 58
Nirzhor, S. S. R., Khan, R. I., & Neelotpol, S. (2018) · Biomolecules · doi:10.3390/biom8030093 · Cited by 61
“In mouse models, these abnormal Ca2+ concentrations have been shown to be associated with the increased activation of P2Y1 receptors and transient receptor potential channel 4 [81,82].”
BackgroundLarramona-Arcas, R., González-Arias, C., Perea, G., Gutiérrez, A., Vitorica, J., García-Barrera, T., Gómez-Ariza, J. L., Pascua-Maestro, R., Ganfornina, M. D., Kara, E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00382-8 · Cited by 56
Purinergic signaling in epilepsy
Rassendren, F., & Audinat, É. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23770 · Cited by 65
“, 2009) and that inhibiting P2Y1 receptors normalizes calcium signaling (Delekate et al., 2014).”
BackgroundNi, R., Rudin, M., & Klohs, J. (2018) · Photoacoustics · doi:10.1016/j.pacs.2018.04.001 · Cited by 55
Hippocampal hyperactivity in a rat model of Alzheimer’s disease
Sosulina, L., Mittag, M., Geis, H., Hoffmann, K., Klyubin, I. V., Qi, Y., Steffen, J., Friedrichs, D., Henneberg, N., Fuhrmann, F., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15323 · Cited by 61
Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease
Bouvier, D. S., & Murai, K. K. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-143156 · Cited by 51
“[163] also resulted in impaired gliotransmitter secre-”
Calcium Signalling Toolkits in Astrocytes and Spatio-Temporal Progression of Alzheimer's Disease
Lim, D., J Rodríguez-Arellano, J., Parpura, V., Zorec, R., Zeidán-Chuliá, F., A. Genazzani, A., & Verkhratsky, A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151116130104 · Cited by 52
Rasmussen, R., Nedergaard, M., & Petersen, N. C. (2016) · Scientific Reports · doi:10.1038/srep30433 · Cited by 51
“The two most likely hypotheses may be that: (1) SR101 has a direct effect on cortical neurones, or (2) SR101 has an indirect effect on neuronal activity via an astrocyte-mediated mechanism.”
Astrocyte Ca2+Signaling Drives Inversion of Neurovascular Coupling after Subarachnoid Hemorrhage
Pappas, A. C., Koide, M., & Wellman, G. C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1551-15.2015 · Cited by 49
“Previously, purinergic signaling was implicated in the hyperactive Ca 2 signaling phenotype observed in reactive astrocytes in an Alzheimer’s disease model (Delekate et al., 2014).”
BackgroundMethodImpaired astrocytic Ca2+ signaling in awake-behaving Alzheimer’s disease transgenic mice
Åbjørsbråten, K. S., Skaaraas, G. H. E. S., Cunen, C., Bjørnstad, D. M., Binder, K. M. G., Bojarskaite, L., Jensen, V., Nilsson, L. N. G., Rao, S. B., Tang, W., et al. (2022) · eLife · doi:10.7554/elife.75055 · Cited by 53
“Methoxy- X04 enters the brain and specifically stains parenchymal Aβ plaques and cerebrovascular deposits (Klunk et al., 2002), and is widely used for in vivo imaging of transgenic mice with Aβ (Delekate et al., 2014; Kuchibhotla et al., 2009; Meyer- Luehmann et al., 2008).”
BackgroundResultInfluentialRole of astrocyte purinergic signaling in epilepsy
Nikolic, L. M., Nobili, P., Shen, W., & Audinat, É. (2019) · Glia · doi:10.1002/glia.23747 · Cited by 53
Glial Purinergic Signaling in Neurodegeneration
Pietrowski, M. J., Gabr, A. A., Kozlov, S. O., Blum, D., Halle, A., & Carvalho, K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.654850 · Cited by 51
Sanjay, S., Sood, R., Jaiswal, V., Kang, S.-U., Park, M., & Lee, H. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103197 · Cited by 57
“The purinergic receptors [14,15], metabotropic glutamate receptor (mGluR)5 [16,17], and α 7 nicotinic acetylcholine receptor ( α 7nAChR) [13,18] have been found to stimulate intracellular calcium level rise from the endoplasmic reticulum (ER) in astrocytes.”
BackgroundRole of Purinergic Receptor P2Y1 in Spatiotemporal Ca2+Dynamics in Astrocytes
Shigetomi, E., Hirayama, Y. J., Ikenaka, K., Tanaka, K. F., & Koizumi, S. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2625-17.2017 · Cited by 44
“…of astrocyte-specific P2Y1R overexpression The P2Y1R can be upregulated in astrocytes in pathophysiological states (Kuboyama et al., 2011; Delekate et al., 2014) and contributes to Ca 2 signals, for example, in Alzheimer disease (Delekate et al., 2014) and epilepsy (Álvarez-Ferradas et al., 2015).”
BackgroundInfluentialToxic amyloid-β oligomers induced self-replication in astrocytes triggering neuronal injury
Wang, W., Hou, T., Jia, L.-F., Wu, Q., Quan, M., & Jia, J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.049 · Cited by 42
“A clue to its onsetmay be the peculiar distribution of AβOs and activated astrocytes in the very early stages of pathology [10,30,31].”
BackgroundGlutathione System and Oxidative Stress in Health and Disease
Bagatini, M. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82965 · Cited by 52
Metadata
- Authors
- Delekate, A., Füchtemeier, M., Schumacher, T., Ulbrich, C., Foddis, M., & Petzold, G. C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- Charité – Universitätsmedizin Berlin (DE)
- University Hospital Bonn (DE)
- Corresponding author
- Petzold, Gabor C.
- Venue
- Nature Communications
- Published
- 2014-11-19
- Volume
- 5
- Issue
- 1
- Pages
- 5422-5422
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2052870901
- Cited by
- 332
- References
- 68
- Citations by year
- 2026: 31 · 2025: 30 · 2024: 26 · 2023: 41 · 2022: 33 · 2021: 30 · 2020: 28 · 2019: 27 · 2018: 24 · 2017: 20 · 2016: 24 · 2015: 18
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, astrocytes, P2Y1 receptor, purinergic signaling, reactive astrogliosis, amyloid plaques, connexin hemichannels, nucleotide release, ADP, cerebral blood flow, P2X receptors
- MeSH terms
- Adenosine Triphosphate, Alzheimer Disease, Animals, Astrocytes, Cerebrovascular Circulation, Disease Models, Animal, Humans, Mice, Transgenic, Signal Transduction, Amyloid beta-Protein Precursor, Calcium Signaling, Microscopy, Fluorescence, Multiphoton, Mice, Plaque, Amyloid, Receptors, Purinergic P2Y1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.